BriaCell Therapeutics Warrant expiring 2031 (BCTXL) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 72 197 sessions, January 14, 2026 to November 5, 2026
- Largest daily move
- -26.6% close of May 15, 2026
- 1-month change
- -30.8% closing prices, October 5, 2026 to November 5, 2026
Company Description
BriaCell Therapeutics Warrant expiring 2031 (NASDAQ: BCTXL) is classified in the pharmaceutical preparations industry.
BCTXL has declined 30.8% over the past month. The last closing price was $0.8100.
For FY2026, BriaCell Therapeutics Warrant expiring 2031 reported net income of -$34.9M and diluted earnings per share of -$6.97.
This page collects what Stock Titan holds for BCTXL, including price data, SEC filings, financial highlights, and short interest trends.
Stock Performance
BriaCell Therapeutics Warrant expiring 2031 (BCTXL) closed at $0.8100 on November 5, 2026. Over the past month, the price has lost 30.8%.
BCTXL Metrics & Rankings
Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
BriaCell Therapeutics Warrant expiring 2031 has filed 10 recent SEC filings, including 5 Form 8-K, 1 Form 10-K, 1 Form 10-Q, 1 Form 424B5. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BCTXL SEC filings →
Financial Highlights
BriaCell Therapeutics Warrant expiring 2031 reported operating income of -$36.1M in FY2026, and net income was -$34.9M. Diluted earnings per share stood at -$6.97. The company generated -$28.7M in operating cash flow.
Upcoming Events
Short Interest History
Short interest in BriaCell Therapeutics Warrant expiring 2031 (BCTXL) currently stands at 5.6 thousand shares, up 45.8% from the previous reporting period. Since January 2026, short interest has decreased by 26.9%.
Days to Cover History
Days to cover for BriaCell Therapeutics Warrant expiring 2031 (BCTXL) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 2.9 days.
BCTXL Company Profile & Sector Positioning
BriaCell Therapeutics Warrant expiring 2031 (BCTXL) and is listed on the NASDAQ.